Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a <scp>SEER</scp>‐medicare analysisSikander Ailawadhi, Asher Chanan‐Khan, Gerardo Colón‐Otero et al.|Cancer Medicine|2017Cited by 88
Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparitiesSikander Ailawadhi, Asher Chanan‐Khan, Ryan D. Frank et al.|Cancer|2018Cited by 55
Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparitiesSikander Ailawadhi, Asher Chanan‐Khan, Jamie Elliott et al.|Blood Cancer Journal|2024Cited by 8
Factors Determining Utilization of Stem Cell Transplant for Initial Therapy of Multiple Myeloma by Patient Race: Exploring Intra-racial Healthcare Disparities.Sikander Ailawadhi, Asher Chanan‐Khan, Jamie Elliott et al.|Research Square|2024Cited by 0